gonorrhea/gin diare

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 48 rezilta yo

Open study of the safety and efficacy of a single oral dose of cefixime for the treatment of gonorrhea in pregnancy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE The intent of this study was to determine the efficacy and tolerance of single dose oral cefixime use in the treatment of pregnant women with endocervical gonococcal carriage. METHODS A retrospective review of clinic records over a 3 year period identified patients treated with a single

Randomized comparative study of 0.5 and 1 g of cefodizime (HR 221) versus 1 g of cefotaxime for acute uncomplicated urogenital gonorrhea.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Uncomplicated urogenital and concomitant oropharyngeal gonorrhea in 424 male and female patients was treated in a randomized comparative study with 0.5 g of cefodizime (89 men and 54 women), 1 g of cefodizime (87 men and 52 women), or 1 g of cefotaxime (86 men and 56 women). The cure rates were 100%

Efficacy and safety of single dose oral delafloxacin compared with intramuscular ceftriaxone for uncomplicated gonorrhea treatment: an open-label, non-inferiority, Phase 3, multicenter, randomized study.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

We evaluated single oral dose delafloxacin versus single intramuscular (IM) ceftriaxone in participants with uncomplicated urogenital gonorrhea (primary objective). Secondary objectives included the efficacy, safety, and tolerability of delafloxacin versus ceftriaxone for uncomplicated

Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

We evaluated single oral dose of delafloxacin versus single intramuscular ceftriaxone in participants with uncomplicated urogenital gonorrhea (primary objective). Secondary objectives included the efficacy, safety, and tolerability of delafloxacin versus ceftriaxone for uncomplicated

Comparative study of treatment of uncomplicated gonorrhea with thiamphenicol and cefotaxime.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Results of treatment of uncomplicated urogenital gonorrhea caused by penicillinase- and non-penicillinase-producing Neisseria gonorrhoeae were compared. In The Hague treatment consisted of thiamphenicol (2.5 g given orally), whereas the treatment in Rotterdam was cefotaxime (1 g given im). All

Treatment of gonorrhea with thiamphenicol.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

For many years thiamphenicol has been the drug of choice for the treatment of uncomplicated gonorrhea at the Center for Venereal Disease of the University of Milan. During the last four years, 1,110 of 1,112 cases of uncomplicated gonorrhea treated with 500 mg of oral thiamphenicol three times a day

Single-dose efficacy of ofloxacin in uncomplicated gonorrhea.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Two multicenter trials compared single-dose oral therapy with 400 mg of ofloxacin or 3 g of amoxicillin plus 1 g of probenecid in the treatment of uncomplicated gonorrhea in 160 men and 102 women. Patients with a known diagnosis of Chlamydia trachomatis infection were excluded. All pretreatment

Single-dose thiamphenicol for the treatment of gonorrhea.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Acute gonococcal urethritis was treated with a single oral dose of 2.5 g of thiamphenicol in 62 patients after diagnosis by gram-staining of urethral smears and/or cultures for Neisseria gonorrhoeae in Thayer-Martin medium. Therapy resulted in bacteriologic and clinical cure in 50 cases. Three cases

[Results of a comparative therapeutic trial of single-dose treatment of non-complicated acute male gonorrhea].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A single dose treatment trial with: spectinomycine 2 g, ampicilline + probenecide 3.5 g + 1 g, thiamphenicol 2.5 g, minocycline 300 mg was undertaken. Three teams were involved, epidemiologists clinicians, microbiologists, 636 patients were included, 483 resumed for control. A negative culture on

A comparison of rosoxacin with ampicillin and probenecid in the treatment of uncomplicated gonorrhea.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Rosoxacin, a beta-lactamase-resistant, pyridyl quinolone derivative with in vitro activity against Neisseria gonorrhoeae, was compared to an oral regimen of ampicillin plus probenecid for the treatment of uncomplicated gonococcal infection. Fifty-seven patients were evaluated for the effectiveness

Historical Spice as a Future Drug: Therapeutic Potential of Piperlongumine.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Spice and spice-derived compounds have been identified and explored for their health benefits since centuries. One of the spice long pepper has been traditionally used to treat chronic bronchitis, asthma, constipation, gonorrhea, paralysis of the tongue, diarrhea, cholera, malaria, viral hepatitis,

[Newborn infant of drug-addicted mother: maternal, perinatal, neonatal aspects, and neonatal abstinence syndrome].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Maternal drug addiction has increased in an alarming way over the last ten years. Therefore, the withdrawal syndrome in the newborn has also increased. 53% of the newborns (of chemical dependent mother) studied from 1985 to 1989 in HCP have presented this syndrome. We have analysed: perinatal,

The place of quinolones in everyday clinical practice.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The new fluoroquinolones have many attributes and relatively few drawbacks. As a result, they have been rapidly adopted for the treatment of serious bacterial infections. The currently available fluoroquinolones are particularly effective for the treatment of urinary tract infections, bacterial

Antimicrobial activity of Securidaca longipedunculata.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The folk herbal uses of Securidaca longipedunculata in the treatment of diarrhea, boils, gonorrhea, and cough prompted phytochemical analyses and antimicrobial activity screening of extracts of the root. Some flavonoids isolated showed activity against many micro-organisms. These flavonoids were

Fluoroquinolone antimicrobial agents.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The fluoroquinolones, a new class of potent orally absorbed antimicrobial agents, are reviewed, considering structure, mechanisms of action and resistance, spectrum, variables affecting activity in vitro, pharmacokinetic properties, clinical efficacy, emergence of resistance, and tolerability. The

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye